136
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Acute myeloid leukemia associated with a novel GATA2 mutation: a case report and the importance to identify GATA2 haplodeficiency

ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 3010-3013 | Received 28 Apr 2020, Accepted 04 Jul 2020, Published online: 27 Jul 2020

References

  • Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809–821.
  • Cavalcante de Andrade Silva M, Katsumura KR, Mehta C, et al. Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome. Leukemia [Internet]. 2020; [cited 2020 Apr 20]; Available from: http://www.nature.com/articles/s41375-020-0820-2.
  • Katsumura KR, Mehta C, Hewitt KJ, et al. Human leukemia mutations corrupt but do not abrogate GATA-2 function. Proc Natl Acad Sci USA. 2018;115(43):E10109–E10118.
  • Zwaan CM, Kolb EA, Reinhardt D, et al. Collaborative efforts driving progress in pediatric acute myeloid leukemia. J Clin Oncol. 2015;33(27):2949–2962.
  • Wang X, Muramatsu H, Okuno Y, et al. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies. Haematologica. 2015;100(10):e398–e401.
  • Hirabayashi S, Wlodarski MW, Kozyra E, et al. Heterogeneity of GATA2-related myeloid neoplasms. Int J Hematol. 2017;106(2):175–182.
  • Donadieu J, Lamant M, Fieschi C, et al. Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients. Haematologica. 2018;103(8):1278–1287.
  • Kurosaki T, Maquat LE. Nonsense-mediated mRNA decay in humans at a glance. J Cell Sci. 2016;129(3):461–467.
  • Liu X, Jiang B, Wang A, et al. GATA2 rs2335052 polymorphism predicts the survival of patients with colorectal cancer. Plos One. 2015;10(8):e0136020.
  • Haddox CL, Carr RM, Abraham RS, et al. Phenotypic heterogeneity associated with germline GATA2 haploinsufficiency: a comprehensive kindred study. Leuk Lymphoma. 2019;60(13):3282–3286.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.